Assignee
APOGENIX GMBH
DE·12 granted patents·8 pending applications·239 citations·filing 2004–2015
Top patents by PatentIndex Score
20 records- 0198US9359420B2Single chain trail fusion polypeptides and encoding nucleic acidsAPOGENIX GMBH·Filed 2014·Granted Jun 7, 2016·66 cites·18 claims
- 0298US9340599B2Single chain CD40L fusion polypeptidesAPOGENIX GMBH·Filed 2014·Granted May 17, 2016·69 cites·16 claims
- 0398US8921519B2Single chain fusion polypeptides comprising soluble light cytokine domainsAPOGENIX GMBH·Filed 2013·Granted Dec 30, 2014·75 cites·15 claims
- 0490US8383774B2Collectin fusion proteins comprising TNF or trailAPOGENIX GMBH·Filed 2008·Granted Feb 26, 2013·12 cites·29 claims
- 0581US9212211B2Trail collectin fusion proteinsAPOGENIX GMBH·Filed 2014·Granted Dec 15, 2015·3 cites·25 claims
- 0678US8907063B2TNF superfamily collectin fusion proteins and encoding nucleic acidsAPOGENIX GMBH·Filed 2013·Granted Dec 9, 2014·2 cites·20 claims
- 0778US8007813B2CD95-Fc fusion proteinsAPOGENIX GMBH·Filed 2004·Granted Aug 30, 2011·11 cites·14 claims
- 0875US9527897B2CD40L collectin fusion proteins and encoding nucleic acid moleculesAPOGENIX GMBH·Filed 2015·Granted Dec 27, 2016·1 cites·22 claims
- 0964US9434783B2Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereofAPOGENIX GMBH·Filed 2013·Granted Sep 6, 2016·0 cites·26 claims
- 1064US9315570B2Composition comprising a mixture of CD95-Fc isoforms and methods of producing sameAPOGENIX GMBH·Filed 2013·Granted Apr 19, 2016·0 cites·19 claims
- 1160US9469681B2Fusion proteins forming trimersAPOGENIX GMBH·Filed 2014·Granted Oct 18, 2016·0 cites·13 claims
- 1259US9540431B2Inhibitors of the CD95 signaling pathway for treatment of MDSAPOGENIX GMBH·Filed 2013·Granted Jan 10, 2017·0 cites·8 claims
- 1358US2009196868A1Methods and compositions for preventing radiation-induced pneumonitisAPOGENIX GMBH·Filed 2008·Application pending·0 cites
- 1457US2015126710A1Fusion proteins forming trimersAPOGENIX GMBH·Filed 2014·Application pending·0 cites
- 1547US2010086515A1Human il-4 muteins in cancer therapyAPOGENIX GMBH·Filed 2007·Application pending·0 cites
- 1646US2010297110A1Antibody specific for human il-4 for the treatment of cancerAPOGENIX GMBH·Filed 2007·Application pending·0 cites
- 1743US2010111969A1Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumorsAPOGENIX GMBH·Filed 2009·Application pending·0 cites
- 1834US2007292389A1Method for the Purification and Amplification of Tumoral Stem CellsAPOGENIX GMBH·Filed 2005·Application pending·0 cites
- 1932US2016103132A1Method of diagnosing cancerAPOGENIX GMBH·Filed 2015·Application pending·0 cites
- 2024US2011171212A1Methods and compositions for preventing radiation-induced pneumonitisAPOGENIX GMBH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APOGENIX GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →